Sleep Disruption in New Mothers: An Intervention Trial
- Conditions
- PregnancyPostpartum PeriodSleep Disturbance
- Interventions
- Registration Number
- NCT01321710
- Lead Sponsor
- University of California, San Francisco
- Brief Summary
The purpose of this study is to test a behavioral intervention to minimize sleep disruption and fatigue in new mothers after the birth of their first infant. This study also tests whether an acetaminophen intervention at the time of an infant's 2-month immunization series improves infant and maternal sleep.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 152
- pregnant women expecting first singleton birth
- able to speak, read, and write in English
- willing to participate for 3 consecutive days and nights during 36-39 weeks gestation and at 4, 8, and 12 weeks postpartum
- willing to have their infant participate in ankle actigraphy recording of their sleep/wake patterns for 96 hrs at the time of their first immunization
- history of affective illness prior to pregnancy
- current use of medications that may alter sleep
- history of a diagnosed sleep disorder such as sleep apnea, nocturnal myoclonus, or narcolepsy
- plan to employ live-in help with child care
- working the night-shift
- multiple pregnancy with twins or more
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Dietary information & standard care Dietary information Mothers in this arm receive dietary information aimed at reducing postpartum sleep disturbance. Infants in this arm receive no intervention beyond standard immunization care. Sleep hygiene & standard care Sleep hygiene Mothers in this arm receive a sleep hygiene intervention aimed at improving their postpartum sleep. Infants in this arm receive standard immunization care. Sleep hygiene & acetaminophen Sleep hygiene Mothers in this arm receive a sleep hygiene intervention aimed at improving postpartum sleep. Infants in this arm receive an acetaminophen intervention (12.5mg per kg infant weight, 1 dose 30 minutes prior to immunization and q4-6h thereafter, for a total of 5 doses) to minimize sleep disturbance following immunization. Sleep hygiene & acetaminophen Acetaminophen Mothers in this arm receive a sleep hygiene intervention aimed at improving postpartum sleep. Infants in this arm receive an acetaminophen intervention (12.5mg per kg infant weight, 1 dose 30 minutes prior to immunization and q4-6h thereafter, for a total of 5 doses) to minimize sleep disturbance following immunization.
- Primary Outcome Measures
Name Time Method Maternal Sleep Quantity (Objective) 1-month postpartum (approximately) Maternal sleep quantity is defined as total night-time sleep in hours as measured by wrist actigraphy over 3 nights.
Maternal Sleep Quality (Objective) 1 month postpartum (approximately) Maternal sleep quality is defined as sleep efficiency (percent sleep per time in bed averaged across 3 nights) as measured by wrist actigraphy.
Change in Infant Sleep Quantity (Objective) 24 hours before and 24 hours after immunizations at approximately 2 months of age Change in infant sleep quantity is defined as the difference between the number of hours slept in the 24 hours prior to immunization and the the number of hours slept after immunization (positive numbers indicate more sleep following immunization). Infant sleep was measured by ankle actigraphy.
- Secondary Outcome Measures
Name Time Method Maternal Sleep Disturbance (Subjective) 1 month postpartum (approximately) Maternal sleep disturbance is measured by the total score on the General Sleep Disturbance Scale (GSDS). The GSDS is a self-report questionnaire that measures perceived sleep disturbance in the past week. GSDS scores range from 0 to 147, with higher scores indicating more sleep disturbance.
Maternal Well-being 1 month postpartum (approximately) Maternal well-being was measured by the total score on the Center for Epidemiologic Studies - Depression Scale (CES-D). The CES-D measures depressive symptoms in the past week. CES-D scores can range 0 to 60, with higher scores indicating more symptoms of depression.
Trial Locations
- Locations (1)
University of California
🇺🇸San Francisco, California, United States